Serial Number
77846790
Owner
Target Health, Inc.Attorney
Kenneth I. KohnFirst Use Date
Jul 7, 2011
Filing Date
Oct 12, 2009
TARGET E*STUDIO Trademark
Serial Number: 77846790
Trademark Classes
Owner Contact Info
305 Madison Avenue, Suite 2501
New York, NY 10165
Entity Type: 11
Legal Representation
Trademark Details
Filing Date
October 12, 2009
Registration Date
Not Registered
First Use Anywhere
July 7, 2011
First Use in Commerce
July 7, 2011
Published for Opposition
July 27, 2010
Goods & Services
Reviewing standards and practices to assure compliance with medical and pharmaceutical laws and regulation; reviewing standards and practices to assure compliance with US Food and Drug Administration (FDA) laws and regulations; legal consulting services regarding Food and Drug law and regulation compliance, namely, consulting in the preparation of legal negotiations, in the preparation of legal documents and forms required by the FDA, in the preparation of responses to FDA questions and warning letters, and the follow-up with the FDA on post application submission questions, in the preparation of meetings with legal counsel; intellectual property licensing in the fields of drug, drug product, pharmaceutical and pharmaceutical products
Providing online computer database for use in gathering and providing clinical trial data regarding medical and scientific research; Scientific research; Technical consultation and research in the medical and pharmaceutical fields; Product research and development; medical and scientific research services in the field of treatment and diagnosis provided for medical service providers; Technical writing for others; Providing quality assurance services in the field of pharmaceuticals; troubleshooting of product and process development problems dealing with safety and regulatory toxicology programs as it relates to medical and scientific research in the development of pharmaceutical drugs; Medical and scientific research, namely, conducting clinical trials; Consultation in the fields of pharmaceutical drug development, conducting clinical trials; consultation in the field of pharmaceuticals drug development, namely, consulting with sponsor, medical, scientific, toxicology, manufacturing and business experts to clearly delineate development requirements and evaluate available and competitive technologies; development of pharmaceutical product processes for others; Technical writing for others, namely, writing integrated clinical and statistical study reports and regulatory manuscripts relating to medical and scientific research in the development of pharmaceutical drugs, as an integrated component; compiling patient records and patient data via a global computer information network for research purposes in the fields of medical science and medical consultancy
